Diclegis: what about NOT to prescribe the only Pregnancy Category A Medication for Morning Sickness?

Pharma targeting cu$tomer$ and doctors directly by mail…

Diclegis: why not NOT prescribe the only Pregnancy Category A Medication for Morning Sickness?
If I were a doctor, I would definitely not prescribe the Diclegis drug

Amazingly, I received an email today, from Diclegis Duchesnay USA – MedIntel@hcpconnects.com – with the subject: “Why Not Prescribe the Only Pregnancy Category A Medication for Morning Sickness?” !!! wow, those guys are targeting cu$tomer$ and doctors directly by mail… they are not selling enough yet? Here are few thoughts regarding why, if I were a doctor, I would definitely not prescribe the Diclegis drug:

Prenatal Exposures: should you be worried?

via “Prenatal Exposures Never Die”: the blog about epigenetics, autism, and the multigenerational tragedy of prenatal pharmaceutical use

Prenatal Exposures: Should You Be Worried?
Autism Exposed: “The” blog about epigenetics, autism, and the multigenerational tragedy of prenatal pharmaceutical use – PrenatalExposures.Blogspot.co.uk

Jill Escher from Autism Exposed addresses those questions in PrenatalExposures.Blogspot.co.uk latest bog post…
read Prenatal Exposures: Should You Be Worried?

Find out more about DES exposure and the long-term health effects associated with prenatal exposure to DES drug.

DES DiEthylStilbestrol Resources

Suspension of FDA Approval urged for new Morning Sickness Drug Diclegis

Another preventable future health tragedy?

#Diclegis is #FDA approved to replace #Bendectin as new Morning Sickness DrugJill Escher, from Prenatal Exposures Never Die, the blog about epigenetics, autism, and the multigenerational tragedy of prenatal pharmaceutical use, wrote to the FDA on April 11. 2013.

I am writing to urgently request that the FDA take immediate steps to suspend approval for the prenatal drug Diclegis pending appropriate safety testing for impacts to fetal germ cells, the precursor cells to the baby’s egg or sperm. In addition, I urge the FDA to take immediate steps to issue warnings regarding potential germline impact of all prenatally administered drugs… ”

Read Suspension of Approval Urged for New Morning Sickness Drug, Diclegis, Pending Assessment of Fetal Germline Impacts, April 11. 2013.

Related post: Diclegis FDA approved to replace Bendectin as new Morning Sickness Drug: future Health Tragedy?.

Diclegis FDA approved to replace Bendectin as new Morning Sickness Drug

Another preventable future health tragedy?

#Diclegis is #FDA approved to replace #Bendectin as new Morning Sickness DrugA new pregnancy drug, the Diclegis® pill manufactured by  Duchesnay Inc. Canada, will enter pharmacies this June 2013.  This week (see tweet), in its news release, the FDA stated: ” The U.S. Food and Drug Administration today approved Diclegis (doxylamine succinate and pyridoxine hydrochloride) to treat pregnant women experiencing nausea and vomiting “.

The “Morning Sickness Drug“, was called Bendectin between 1978 and 1983, and had over 300 lawsuits filed against the Merrell Dow pharmaceutical company, claiming damages for babies with deformities born to mothers who took the drug. The wide range of birth defects attributed to it were: limb and other musculoskeletal deformities; facial and brain damage; defects of the respiratory, gastrointestinal, cardiovascular and genital-urinary systems; blood disorders and cancer.

With many thanks to Judith Kavanaugh for warning me about this unbelievable but true news !!!

More information